Solid Biosciences Inc. (SLDB) Cash Flow Quarterly - Discounting Cash Flows
SLDB
Solid Biosciences Inc.
SLDB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
Report Filing: 2025-11-03 2025-11-03 2025-08-12 2025-05-15 2025-03-06 2024-11-06 2024-08-13
1234
Net Income/Starting Line -167.1 -45.78 -39.48 -39.28 -42.6 -32.73 -25.07
1234
Cash From Operating Activities -132.4 -33.47 -37.41 -31.85 -29.64 -23.71 -21.47
1234
Depreciation and Amortization -0.639 -1.05 -0.488 0.407 0.488 0.405 1.24
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 14.23 3.93 3.15 3.34 3.82 3 2.09
1234
Other Non-Cash Items 12.6 2.25 1.95 1.89 6.51 2.78 0.2
1234
Changes in Working Capital 8.56 7.17 -2.54 1.79 2.13 2.84 0.078
1234
Accounts Receivable 0 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable 4.98 3.7 0.006 0.461 0.815 0.918 1.07
1234
Deferred Revenue 3.58 3.48 -2.54 1.33 1.31 1.92 -0.99
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -66.9 -45.27 -32.73 -27.46 38.57 -10.99 -5.18
1234
Investments in Property Plant and Equipment -0.792 -0.085 -0.377 -0.126 -0.204 -0.015 -0.286
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities -227.3 -83.19 -63.44 -65.34 -15.33 -85.47 -20.19
1234
Sales and Maturities of Investments 161.1 38 31 38 54.1 74.5 15.3
1234
Other Investing Activities 0.085 0 0.085 0 0 0 0
1234
Cash From Financing Activities 196.2 1.18 -1.6 189.7 6.94 3.26 5
1234
Debt Repayment -0.648 -0.243 -0.142 -0.135 -0.128 -0.12 -0.225
1234
Common Stock Issued 196.5 1.42 -1.66 189.9 6.86 3.1 5.36
1234
Common Stock Repurchased -0.02 0 0 -0.02 0 -5.11 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 0.407 0 0.196 0 0.211 5.39 -0.132
1234
Effect of Forex Changes on Cash 0 0 0 0 0 0 -0.077
1234
Net Change in Cash -18.9 -77.57 -71.75 130.4 15.86 -31.44 -21.72
1234
Cash at Beginning of Period 82.19 140.9 212.6 82.19 66.33 97.76 117.6
1234
Cash at End of Period 63.29 63.29 140.9 212.6 82.19 66.33 95.85
1234
Free Cash Flow -133.2 -33.56 -37.79 -31.98 -29.85 -23.72 -21.75
1234
Operating Cash Flow -132.4 -33.47 -37.41 -31.85 -29.64 -23.71 -21.47
1234
Capital Expenditure -0.792 -0.085 -0.377 -0.126 -0.204 -0.015 -0.286
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program